Lixa
About:
Lixa develops revolutionary, scalable solutions for antimicrobial resistance (AMR) and the US$5T per annum biofilm problem.
Website: https://www.lixa.life/
Description:
Lixa solves recurring, problematic microbial infections and contaminations.
Total Funding Amount:
2.2M AUD
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Perth, Western Australia, Australia
Founded Date:
2021-01-01
Founders:
Maud Eijkenboom
Number of Employees:
1-10
Last Funding Date:
2022-09-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai